IL297885A - Hard capsule dosage form and its uses - Google Patents
Hard capsule dosage form and its usesInfo
- Publication number
- IL297885A IL297885A IL297885A IL29788522A IL297885A IL 297885 A IL297885 A IL 297885A IL 297885 A IL297885 A IL 297885A IL 29788522 A IL29788522 A IL 29788522A IL 297885 A IL297885 A IL 297885A
- Authority
- IL
- Israel
- Prior art keywords
- hydroxyvitamin
- dosage form
- formulation
- hard capsule
- calcifediol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063032714P | 2020-05-31 | 2020-05-31 | |
| PCT/IB2021/000220 WO2021205225A1 (en) | 2020-04-06 | 2021-04-06 | 25-hydroxyvitamin d for the treatment of sars-cov-2 infection |
| PCT/IB2021/000376 WO2021245458A1 (en) | 2020-05-31 | 2021-05-31 | Hard capsule dosage form and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL297885A true IL297885A (en) | 2023-01-01 |
Family
ID=78831505
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL297885A IL297885A (en) | 2020-05-31 | 2021-05-31 | Hard capsule dosage form and its uses |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20230293552A1 (https=) |
| EP (1) | EP4157231A1 (https=) |
| JP (1) | JP2023526980A (https=) |
| KR (1) | KR20230017192A (https=) |
| CN (2) | CN120694962A (https=) |
| AU (1) | AU2021285494A1 (https=) |
| CA (1) | CA3181945A1 (https=) |
| IL (1) | IL297885A (https=) |
| WO (1) | WO2021245458A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120694962A (zh) * | 2020-05-31 | 2025-09-26 | 艾尔金制药有限公司 | 硬胶囊剂型和其用途 |
| CN119907688A (zh) * | 2022-09-20 | 2025-04-29 | 比利时胶囊公司 | 含有氧化镁的遮光硬胶囊 |
| WO2025094144A1 (en) | 2023-11-02 | 2025-05-08 | Eirgen Pharma Ltd. | Controlling loss of kidney function |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5264223A (en) | 1990-03-29 | 1993-11-23 | Japan Elanco Company, Ltd. | Hard capsule for pharmaceutical drugs and method for producing the same |
| US5431917A (en) | 1992-10-08 | 1995-07-11 | Japan Elanco Company, Ltd. | Hard capsule for pharmaceutical drugs and method for producing the same |
| US5756123A (en) * | 1994-12-01 | 1998-05-26 | Japan Elanco Co., Ltd. | Capsule shell |
| FR2757173A1 (fr) | 1996-12-17 | 1998-06-19 | Warner Lambert Co | Compositions polymeres d'origine non-animale pour la formation de films |
| KR100379674B1 (ko) | 2000-03-06 | 2003-04-10 | 주식회사 서흥캅셀 | 펙틴과 글리세린의 배합용액을 이용한 셀룰로오스 캅셀 및그의 제조방법 |
| CA2519208A1 (en) * | 2003-03-17 | 2004-09-30 | Takeda Pharmaceutical Company Limited | Controlled release composition |
| ES2593047T3 (es) | 2006-02-03 | 2016-12-05 | Opko Renal, Llc | Tratamiento de la insuficiencia y deficiencia de vitamina D con 25-hidroxivitamina D2 y 25-hidroxivitamina D3 |
| ES2670029T3 (es) * | 2006-06-21 | 2018-05-29 | Opko Ireland Global Holdings, Ltd. | Terapia usando agente de repleción de la vitamina D y agente de reemplazo de la hormona de la vitamina D |
| CN101595133B (zh) * | 2006-10-27 | 2012-11-14 | 比利时胶囊公司 | 羟丙基甲基纤维素硬胶囊及制备方法 |
| KR20190028822A (ko) * | 2007-04-25 | 2019-03-19 | 사이토크로마 인코포레이티드 | 비타민 ｄ 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물 |
| HUE073014T2 (hu) * | 2007-04-25 | 2025-12-28 | Opko Renal Llc | Eljárás a másodlagos hyperparathyreoidismus biztonságos és hatékony kezelésére és megelõzésére krónikus vesebetegség esetén |
| EP2321273B1 (en) * | 2008-07-24 | 2014-11-19 | Wisconsin Alumni Research Foundation | Once-a-week administration of 25-hydroxy vitamin d3 to sustain elevated steady-state pharmacokinetic blood concentration |
| US8852631B2 (en) * | 2009-09-24 | 2014-10-07 | Capsugel Belgium Nv | Acid resistant capsules |
| KR20140072715A (ko) * | 2012-12-05 | 2014-06-13 | 삼성정밀화학 주식회사 | 경질 캡슐 |
| JP2014172850A (ja) * | 2013-03-07 | 2014-09-22 | Capsugel Belgium Nv | ハードカプセル製剤 |
| KR101847947B1 (ko) | 2013-03-15 | 2018-05-28 | 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 | 안정화되고 변형된 비타민 ｄ 방출 제형 |
| US10220047B2 (en) * | 2014-08-07 | 2019-03-05 | Opko Ireland Global Holdings, Ltd. | Adjunctive therapy with 25-hydroxyvitamin D and articles therefor |
| JP7032322B2 (ja) * | 2016-03-28 | 2022-03-08 | オプコ アイルランド グローバル ホールディングス リミテッド | ビタミンｄ治療法 |
| BR112020000011A2 (pt) * | 2017-07-11 | 2020-07-21 | Qualicaps Co., Ltd. | cápsula dura entérica |
| JP7603000B2 (ja) | 2018-08-31 | 2024-12-19 | オプコ アイルランド グローバル ホールディングス リミテッド | ビタミンｄ小児用剤形、製造方法および使用方法 |
| US20210308151A1 (en) * | 2020-04-06 | 2021-10-07 | Eirgen Pharma Ltd. | Activating endogenous antimicrobials to treat sars-cov-2 infection |
| CN120694962A (zh) * | 2020-05-31 | 2025-09-26 | 艾尔金制药有限公司 | 硬胶囊剂型和其用途 |
-
2021
- 2021-05-31 CN CN202510867968.2A patent/CN120694962A/zh active Pending
- 2021-05-31 JP JP2022571817A patent/JP2023526980A/ja active Pending
- 2021-05-31 AU AU2021285494A patent/AU2021285494A1/en active Pending
- 2021-05-31 IL IL297885A patent/IL297885A/en unknown
- 2021-05-31 KR KR1020227041029A patent/KR20230017192A/ko active Pending
- 2021-05-31 EP EP21748934.3A patent/EP4157231A1/en active Pending
- 2021-05-31 CN CN202180038341.6A patent/CN115768412A/zh active Pending
- 2021-05-31 US US18/005,946 patent/US20230293552A1/en active Pending
- 2021-05-31 CA CA3181945A patent/CA3181945A1/en active Pending
- 2021-05-31 WO PCT/IB2021/000376 patent/WO2021245458A1/en not_active Ceased
-
2023
- 2023-05-18 US US18/199,117 patent/US20230330110A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN115768412A (zh) | 2023-03-07 |
| WO2021245458A1 (en) | 2021-12-09 |
| CN120694962A (zh) | 2025-09-26 |
| EP4157231A1 (en) | 2023-04-05 |
| KR20230017192A (ko) | 2023-02-03 |
| US20230293552A1 (en) | 2023-09-21 |
| AU2021285494A1 (en) | 2022-12-08 |
| JP2023526980A (ja) | 2023-06-26 |
| US20230330110A1 (en) | 2023-10-19 |
| CA3181945A1 (en) | 2021-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230330110A1 (en) | Hard capsule dosage form and uses thereof | |
| EP4035657B1 (en) | Drug composition containing abiraterone acetate, and preparation method therefor and application thereof | |
| ES2834900T3 (es) | Formulación de vitamina d de liberación modificada estabilizada y procedimiento de administración de la misma | |
| IL280937B1 (en) | Vitamin d pediatric dosage forms, methods of making and using | |
| US20210386817A1 (en) | Formulations comprising cyclosporin a | |
| IL287698B2 (en) | Complementary therapy with hydroxyvitamin D and preparations containing it | |
| JP7032322B2 (ja) | ビタミンｄ治療法 | |
| JP7817409B2 (ja) | Ｅｐａ－ｅｅナノ脂質組成物、その製剤、調製方法及び使用 | |
| IL302141A (en) | DELAYED RELEASE CYSTEAMINE Bead FORMULATION, and methods of making and using same | |
| US6805880B1 (en) | Pharmaceutical delivery system for vitamin C and vitamin E and use of a combination of vitamin C and E for preventing or treating conditions involving oxidative stress | |
| KR20210116432A (ko) | 화학요법으로 유발된 메스꺼움 및 구토 치료를 위한 방법 및 제형 | |
| CN100531720C (zh) | 一种羟基喜树碱长循环纳米脂质载体及其制备方法 | |
| EP3452095B1 (en) | Simmondsin formulation | |
| IL297338A (en) | Methods and compositions for treating prostate cancer | |
| TWI743426B (zh) | 經穩定之修飾釋放維他命d調配物及其服用方法 | |
| HK40033528A (en) | Stabilized modified release vitamin d formulation and method of administering same | |
| EA046180B1 (ru) | Фармацевтический состав флороглюцинола и триметилфлороглюцинола |